Clinical Trials
3 trialsNCT06388252 2026-02-19
Electrochemotherapy Changes in Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Melanoma Patients
Institute of Oncology Ljubljana
Phase NA Enrolling by invitation
NCT07404605 2026-02-19
Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma
Institute of Oncology Ljubljana
Phase NA Recruiting
NCT03448666 2024-09-23
ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases
European Institute of Oncology
Phase 2 Withdrawn